Newly found pathway drives production of cancer proteins such as KRAS

· Health · United States

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown mechanism that helps cancer cells selectively produce proteins driving tumor growth, including KRAS, in common cancers. The findings suggest that targeting a specific enzyme may improve responses to targeted therapies. The work links a newly described production pathway to some of the most commonly mutated cancer-driving proteins, opening a potential route for combination approaches. No clinical data are reported in the available summary.

Why it matters：KRAS is among the most sought-after cancer targets, and a new production pathway could give drugmakers a way to attack tumors that resist existing targeted therapies.

Key points

  • The mechanism lets cancer cells selectively produce tumor-driving proteins
  • KRAS is named among the affected proteins in common cancers
  • Targeting a specific enzyme could improve targeted-therapy response

Sources (original reporting)

More stories from this day